← Leaderboards
Lalitha Iver
Sri International
$411,035
Attributed
$411,035
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $171K · FY2016–18$200K$150K$100K$50K$0
'16
'17
'18
Funding mix
By agency
NIH$411,035 · 1
By mechanism
N01$411,035 · 1
Top collaborators
No co-investigators on record.
Most similar at Sri International
Same institution · by research overlap
- Peter D Karp$58,896,021
- Carol E Green$19,982,282
- Nurulain T Zaveri$24,519,975
- Adolf Pfefferbaum$63,604,427
- Debra Burnin$9,670,591
Others in their field
Top investigators on “Regulation”
- Kiyoshi Suyehiro · Iodp Management International, Inc$166,539,344
- David Heimbrook · Leidos Biomedical Research, Inc.$152,164,826
- Ralph Parchment · Leidos Biomedical Research, Inc.$141,315,269
- Nevan J Krogan · University Of California, San Francisco$101,337,442
- Asimah Rafi · Technical Resources Inc$95,881,052
- Richard C Boucher · University Of North Carolina Chapel Hill$83,460,414
Research focus
RegulationData FilesLiquid SubstanceProtocols DocumentationResearch PersonnelUnited States Food And Drug AdministrationInvestigational DrugsIn VitroNational Institute Of Drug AbusePharmaceutical PreparationsReportingAnimalsAdme StudySecureBiologicalAnalytical MethodElectronic DataBiological AvailabilityContractorMetabolismAbsorptionNovel TherapeuticsDosage FormsDosage
Grant awards (3)
IGF::OT::IGF: TASK ORDER 02 MOD 01. NON-CLINICAL ADME STUDIES. POP: 09/19/2016 - 09/18/2021. N01DA-16-8931.PURPOSE: TO OBLIGATE FUNDS TO FULLY FUND PERFORMANCE UNDER TASK ORDER 02 MODIFICATION 02 AN$119,962
N01 · FY2018 · DA · contact PI
IGF::OT::IGF: Non-Clinical ADME Studies. N01DA-16-8931.$120,097
N01 · FY2017 · DA · contact PI
IGF::OT::IGF: Non-Clinical ADME Studies. N01DA-16-8931.$170,976
N01 · FY2016 · DA · contact PI